Two Americans who contracted Ebola in West Africa have been given a clean bill of health. It's one positive story that has come out of the West African Ebola outbreak, but what role did the experimental drug ZMapp, whose availability has sparked controversy, have on their recovery?
During a global health reporting trip to Mozambique, Sonia Narang witnessed the challenges women and children face in one of the least developed countries in the world. Thus was born "The Women of Mozambique," a week long Instagram series that illuminates the lives of women through short vignettes.
Across West Africa, there's widespread suspicion about Ebola — even down to whether the disease actually exists. To help spread accurate information, radio stations are playing catchy songs with vital information about the disease.
A year-long investigation by the New York Times shows the huge unmet need for kidney transplants across the world, and how Costa Rica has become a key place for people willing to buy themselves off of massive waiting lists.
More than a dozen Ebola patients in Liberia have gone missing after a mob attacked and looted a Monrovia-area health facility. Now, the Liberian government fears that infected individuals are returning to their communities, where they risk spreading the virus.
After 10 years of failed treatments, a woman with previously incurable bone marrow cancer is now in remission. That's thanks to doctors at the Mayo Clinic in Rochester, Minn., who turned a form of the measles virus into a promising cancer-killing machine
The medical relief agency Doctors Without Borders says the Ebola outbreak in West Africa is like fighting a war, and the battle has now reached Nigeria. With huge, tightly-packed cities, the country could be in serious trouble if cases aren't contained.
Doctors in West Africa are having a tough time battling Ebola since they're lacking the most basic supplies — like gloves and masks. Dr. Roseda Marshall, the chair of pediatrics at the University of Liberia's Dogliotti College of Medicine, says the world is wasting time while the epidemic spreads.
Was it right to give an experimental serum to two people infected with Ebola? Was it right to give it to white Americans and not Africans? Kevin Fitzgerald, who's a medical ethicist at Georgetown University and a Jesuit priest, discusses the circumstances.
The story you just read is freely available and accessible to everyone because readers like you support The World financially.
Thank you all for helping us reach our goal of 1,000 donors. We couldn’t have done it without your support. Your donation directly supported the critical reporting you rely on, the consistent reporting you believe in, and the deep reporting you want to ensure survives.